Overexpression of SDF-1 has been reported to be associated with inflammatory diseases, such as rheumatoid arthritis (RA), acute myocardial infarction, pelvic inflammatory disease (PID), and pathogenesis of atherosclerosis [14–16] as well. Here, CXCL12 is linked to myocardial infarction.